MENU

New federal price controls could hurt launch of new drugs

By The IJ Staff | Feb. 4, 2020, 11:08 a.m.

Photo: Unsplash

Ottawa’s new price controls for patented medicines in Canada are causing delayed product launches and a loss of jobs in the pharmaceutical industry, according to a survey of senior executives conducted for Life Sciences Ontario.

This article is reserved to PRO Level subscribers

Discover the PRO Level
Advertisement
Related topics …